Skip to content
Checked.be
Complete company report
Generated 18-07-2026
Active BE 0434.737.865Public limited company

DEBA PHARMA

Dumolinlaan 13 ·8510 Kortrijk, Belgium· 38 yrs active
Sector: NACE 21201 (21201)
Conclusion Checked

The computed 12-month bankruptcy probability of DEBA PHARMA is 0.3% (very low). The 2024 annual accounts show equity of €5.96M and a net result of €1.81M. Equity is growing by ~14.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 46 sector peers (fiscal year 2024). The company has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.
Key figures
Equity €5.96M
Net result €1.81M
Staff (FTE) 0.7
Better than sector 95%
Snowflake analysis 5 axes · computed by Checked
Health100Profitability100Solvency100Growth78Stability100
96 / 100

Exceptional profile, strong across almost every axis.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 100
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%
Long track record −Annual accounts: healthy financial profile −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Long-established
Founded in 1988, 38 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Health barometer FY 2024 · computed
100 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Financial overview10 NBB filings
Annual accounts filed on 14-07-2025 with the NBB · fiscal year 2024 · verkort
€0€1.00M€2.00MOperating result 2020: €1.56M€1.56MNet result 2020: €1.20M€1.20MOperating result 2021: €1.54M€1.54MNet result 2021: €1.17M€1.17MOperating result 2022: €1.88M€1.88MNet result 2022: €1.42M€1.42MOperating result 2023: €1.98M€1.98MNet result 2023: €1.53M€1.53MOperating result 2024: €2.34M€2.34MNet result 2024: €1.81M€1.81M20202021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~14.8%/year over 7 fiscal years, indicative, assuming unchanged policy.
€2.00M€4.00M€6.00M€8.00M€10.00M2025: €7.05M (€6.58M - €7.53M)2026: €7.73M (€7.24M - €8.21M)2027: €8.40M (€7.73M - €9.06M)2018: €2.52M2019: €2.52M2020: €3.65M2021: €4.54M2022: €5.29M2023: €5.71M2024: €5.96M2018201920202021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 21 · compared across all schema types (micro, abbreviated and full combined)
Metric This company Sector median Position in the sector
Solvency 93.7% 46.9%
better than 95% of 46 sector peers
Net result €1.81M €-1k
better than 95% of 46 sector peers
Equity €5.96M €108k
better than 87% of 46 sector peers
Gross operating margin €2.52M €28k
better than 95% of 42 sector peers
Total assets €6.36M €284k
better than 86% of 46 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€2.47M
+16.2% far above sector median
Net profit
€1.81M
+18.6% far above sector median
Cash flow
€1.95M
+16.5% far above sector median
Total assets
€6.36M
-0.3% far above sector median
Equity
€5.96M
+4.4% far above sector median
Working capital
€4.80M
+5.9% far above sector median
Employees (FTE)
1
+40.0% +250% vs sector
Staff costs
€34k
+58.4% far above sector median
Income taxes
€594k
+18.0% far above sector median
Dividends
€1.50M
+42.9% 18-24
Debt
€368k
-42.2% far above sector median
Debt ≤ 1y
€346k
-38.4% far above sector median
Debt > 1y
€21k
-70.6% -90% vs sector
Current ratio
14.86
+64.0% far above sector median
Quick ratio
11.03
+72.0% +273% vs sector
Solvency
93.7%
+4.8% +37% vs sector
Debt / equity
0.06
-44.7% -87% vs sector
ROE
30.4%
+13.6% -56% vs sector
ROA
28.5%
+19.0% -40% vs sector
Interest coverage
1206.16
+62.5% far above sector median
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€2.47M
Net profit€1.81M
Cash flow€1.95M
Staff costs€34k
Income taxes€594k
Dividends€1.50M
Total assets€6.36M
Equity€5.96M
Debt€368k
of which ≤ 1y€346k
of which > 1y€21k
Working capital€4.80M
Employees (FTE)0.7
Ratios (computed)
2024
Current ratio14.86
Quick ratio11.03
Working capital ratio75.4%
Solvency93.7%
Debt / equity0.06
Long-term debt ratio0.00
Interest coverage1206.16
Gross margin-
Net margin-
ROA28.5%
ROE30.4%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€6.36M
Fixed assets 21/28€1.22M
Intangible fixed assets 21€11k
Tangible fixed assets 22/27€1.21M
Current assets 29/58€5.14M
Stocks & contracts in progress 3€1.33M
Amounts receivable within one year 40/41€533k
Investments 50/53€1.01M
Cash & bank 54/58€2.25M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€6.36M
Equity 10/15€5.96M
Contributions / capital 10/11€62k
Reserves 13€5.84M
Accumulated profits (losses) 14€0
Provisions & deferred taxes 16€32k
Amounts payable 17/49€368k
Amounts payable after one year 17€21k
Amounts payable within one year 42/48€346k
Trade debts payable within one year 44€188k
Income statement
Gross operating margin 9900€2.52M
Operating result 9901€2.34M
Financial income 75€67k
Financial charges 65€2k
Result before taxes 9903€2.40M
Income taxes 67/77€594k
Net result for the period 9904€1.81M
Result to be appropriated 9905€1.82M
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.
Legal Structure
NACE primary 21201
Legal form Public limited company(014)
Incorporation15-07-1988
StatusActive
Postal code8510
Establishment units 1 location
DEBA PHARMA NV
Dumolinlaan 13, 8510 KortrijkVervaardiging van geneesmiddelen
since 19882.039.328.097
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34026A0406/00P000 Flanders 4,439 m² 1 · 1,079 m² 0.0 m
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 11 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025
06-10-2025
State Gazette act Director changes
14-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · verkort
2024
27-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · verkort
2023
19-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · verkort
2022
18-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · verkort
2021
08-07-2021
NBB filing Annual accounts filed
fiscal year 2020 · verkort
2020
16-06-2020
NBB filing Annual accounts filed
fiscal year 2019 · verkort
2019
17-07-2019
NBB filing Annual accounts filed
fiscal year 2018 · verkort
2018
12-07-2018
NBB filing Annual accounts filed
fiscal year 2017 · verkort
2017
26-07-2017
NBB filing Annual accounts filed
fiscal year 2016 · verkort
2016
11-07-2016
NBB filing Annual accounts filed
fiscal year 2015 · verkort
Belgisch Staatsblad, acts 1 acts
All acts · 1 updated 9 months ago
2025
06-10-2025 7 reappointed Director changes
  • Johan DEJONGHE, Bestuurder
  • Kristof DEJONGHE, Bestuurder
  • Vincent DEJONGHE, Bestuurder
  • Frederik DEJONGHE, Bestuurder
  • Ingrid BAEKELANDT, Bestuurder
  • Johan DEJONGHE, Bestuurder
  • Johan DEJONGHE, Gedelegeerd bestuurder
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Johan DEJONGHE",
        "address": "Neerhofstraat 43, 8560 WEVELGEM",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering beslist, eensgezind, te herbenoemen tot bestuurder voor een hernieuwbare periode van zes jaar: - de heer Johan DEJONGHE, wonende te Neerhofstraat 43, 8560 WEVELGEM",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kristof DEJONGHE",
        "address": "Ten Bosse 12, 9800 DEINZE",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering beslist, eensgezind, te herbenoemen tot bestuurder voor een hernieuwbare periode van zes jaar: - de heer Kristof DEJONGHE, wonende te Ten Bosse 12, 9800 DEINZE",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent DEJONGHE",
        "address": "Moerstraat 36, 8560 WEVELGEM",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering beslist, eensgezind, te herbenoemen tot bestuurder voor een hernieuwbare periode van zes jaar: - de heer Vincent DEJONGHE, wonende te Moerstraat 36, 8560 WEVELGEM",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Frederik DEJONGHE",
        "address": "Neerhofstraat 45, 8560 WEVELGEM",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering beslist, eensgezind, te herbenoemen tot bestuurder voor een hernieuwbare periode van zes jaar: - de heer Frederik DEJONGHE, wonende te Neerhofstraat 45, 8560 WEVELGEM",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ingrid BAEKELANDT",
        "address": "Neerhofstraat 43, 8560 WEVELGEM",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": "0454.197.352",
        "name": "INFICOM BV",
        "address": "Dumolinlaan 13, 8510 MARKE",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "INFICOM BV, met maatschappelijke zetel te Dumolinlaan 13, 8510 MARKE (KORTRIJK) en ondernemingsnummer 0454.197.352, vertegenwoordigd door haar vaste vertegenwoordiger mevrouw Ingrid BAEKELANDT, wonende te Neerhofstraat 43, 8560 WEVELGEM",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Johan DEJONGHE",
        "address": "Neerhofstraat 43, 8560 WEVELGEM",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad van Bestuur beslist, eensgezind, de heer Johan DEJONGHE, wonende te Neerhofstraat 43, 8560 WEVELGEM, te herbenoemen tot gedelegeerd bestuurder.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_renew",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Johan DEJONGHE",
        "address": "Neerhofstraat 43, 8560 WEVELGEM",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad van Bestuur beslist, eensgezind, de heer Johan DEJONGHE, wonende te Neerhofstraat 43, 8560 WEVELGEM, te herbenoemen tot gedelegeerd bestuurder.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Luik",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-10-06",
    "filing_date": "2025-09-22",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-06-30",
      "unanimous": true
    },
    {
      "body": "raad_van_bestuur",
      "date": "2025-06-30",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0434.737.865",
    "name_full": "DEBA PHARMA",
    "legal_form": "NV",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE) Crossroads Bank
Activities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen24421Groothandel in andere voedingsmiddelen, n.e.g.46389Groothandel in andere voedingsmiddelen, neg46389Overige gespecialiseerde groothandel in voedingswaren51384Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primary activity highlighted.
Names & trade names
Legal nameNL DEBA PHARMA
Registered office
Dumolinlaan 13
8510 Kortrijk, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
EXOTHERA BE 0744.643.660 · Charleroi
GRAFTYS BE 0676.661.805 · Liège
Obulytix BE 0803.351.624 · Gent
Upjohn BE 0552.558.025 · Hoeilaart
Temmune Therapeutics BE 0776.938.722 · Mechelen
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative